News
Click title to open press release
SurModics Acquires Drug Delivery Assets of PR Pharmaceuticals- Broadens Portfolio of Proprietary Drug Delivery Technologies; Adds Multiple Customer Development Programs
November 4, 2008
Jerini Ophthalmic and PR Pharmaceuticals Sign Collaboration Agreement to Develop Sustained-Release Formulations for the Treatment of Eye Diseases
April 10, 2008
December 7, 2007
Jerini Ophthalmic Treats First Patient in Phase I Trial for Age-Related Macular Degenration
October 9, 2007
FDA Accepts Jerini Ophthalmic's IND of JSM 6427 for the Treatment of AMD
July 13, 2007
Jerini Announces Establishment of Wholly-Owned US Subsidiary Aimed at Developing Treatments for Eye Diseases
March 20, 2007
